ELRIG UK and The Protein Society partner to advance protein sciences in drug discovery

By Liza Laws

- Last updated on GMT

© Getty Images
© Getty Images

Related tags Drug discovery Drug development Protein Research

ELRIG UK, a leading organization in the drug discovery community, has partnered with The Protein Society (TPS) to host a groundbreaking conference on ‘Protein Sciences in Drug Discovery’.

This collaboration aims to unite experts from various fields to explore how emerging protein science can address the challenges in drug discovery.

ELRIG UK, known for its commitment to delivering high-quality scientific conferences and networking events, focuses on innovative research that can transform drug discovery. TPS, an international scholarly society dedicated to advancing protein research, will bring its extensive expertise to this joint event. Together, they will create an interdisciplinary forum that fosters collaboration and knowledge exchange among scientists from academia, biopharma, and CROs.

Protein Sciences in Drug Discovery 2024 will take place from 18–19 November at Hinxton Hall Conference Centre in Cambridge, UK. This interactive event will feature discussions on high-throughput protein expression, antigen generation for antibody and vaccine discovery, analytical techniques for protein quality assessment, and the use of cryogenic electron microscopy (cryo-EM) in evaluating druggability. The conference will also cover sequence-based predictive methods and include poster presentations, networking sessions, and a vendor exhibition. Additionally, travel bursaries will be available for early career professionals.

Melanie Leveridge

Melanie Leveridge, Chair of ELRIG UK and Vice President of Discovery Biology at AstraZeneca, said: “Our organizations share a unifying goal — to provide a platform that enables academia and industry to exchange knowledge that supports innovation and fosters collaboration across the life science community. We are delighted to join forces with the renowned Protein Society to deliver this year’s Protein Sciences in Drug Discovery event.”

Prof Elizabeth Meiering, president of The Protein Society and professor at the University of Waterloo, added: “We are excited to launch this unique interdisciplinary event in partnership with ELRIG. Bringing together leading experts from complementary disciplines provides an exceptional opportunity to communicate the latest advances and techniques in protein science and how to apply them to support drug discovery. We look forward to connecting our community with its global drug discovery network.”

Elizabeth Meiering

The collaboration between ELRIG UK and The Protein Society promises to advance the field of protein sciences, providing invaluable insights and fostering innovation in drug discovery. This event’s key highlights include high-throughput protein expression, antigen generation, protein quality assessment, cryo-EM, and sequence-based predictive methods.

There will be many opportunities including poster presentations, networking sessions, vendor exhibition, and travel bursaries for early career professionals. 

Related news

Show more

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...

Follow us

Webinars

Headlines